It’s not transport—it’s an operation. Moving Monstermax 2 comes with a five-figure bill before the wheels even roll.

AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...